Clinuvel Pharmaceuticals Limited (FRA:UR9A)
6.05
+0.15 (2.54%)
At close: Nov 26, 2025
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of €336.77 million as of December 1, 2025. Its market cap has decreased by -19.63% in one year.
Market Cap
336.77M
Enterprise Value
210.52M
Revenue
53.04M
Ranking
n/a
PE Ratio
16.68
Stock Price
€6.05
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 3.03M to 336.77M, an increase of 11,018.11%. That is a compound annual growth rate of 20.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 336.09M | -6.66% |
| Dec 31, 2024 | 360.06M | -27.20% |
| Dec 29, 2023 | 494.62M | -27.36% |
| Dec 30, 2022 | 680.95M | -20.78% |
| Dec 31, 2021 | 859.58M | 23.58% |
| Dec 31, 2020 | 695.55M | -20.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |